Analytical Data
-
基因名
CU
- Application
-
别名
CU；C21orf120；C21orf62；CU062；Exosomal polycystin-1-interacting Protein
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q9NYP8
-
表达区间
1-219aa
-
氨基酸序列
MAPPSRHCLLLISTLGVFALNCFTKGQKNSTLIFTRENTIRNCSCSADIRDCDYSLANLMCNCKTVLPLAVERTSYNGHLTIWFTDTSALGHLLNFTLVQDLKLSLCSTNTLPTEYLAICGLKRLRINMEAKHPFPEQSLLIHSGGDSDSREKPMWLHKGWQPCMYISFLDMALFNRDSALKSYSIENVTSIANNFPDFSYFRTFPMPSNKSYVVTFIY
-
分子量
24.8 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
The study of Cu (copper) recombinant proteins has gained significant interest in recent years due to their pivotal roles in various biological processes and their potential applications in biotechnology and medicine. Copper is an essential trace metal that serves as a cofactor for many enzymes involved in redox reactions, neurobiology, and cellular signaling. However, its dysregulation can lead to toxic effects and contribute to diseases such as Wilson’s disease and neurodegenerative disorders. The production of Cu recombinant proteins through recombinant DNA technology allows researchers to study the structure-function relationships of copper-dependent proteins in a controlled manner. This method enables the synthesis of proteins that might be difficult to isolate from natural sources, providing insights into their biochemical mechanisms and interactions. Additionally, these recombinant proteins can be modified to enhance their properties for therapeutic uses, including targeted drug delivery systems or as biomarkers for disease diagnosis. Overall, the exploration of Cu recombinant proteins not only deepens our understanding of fundamental biological processes but also opens new avenues for innovative treatments and diagnostic tools in medicine.
